Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Internal Model Harmonisation Approval

14 Sep 2021 14:07

RNS Number : 7533L
Phoenix Group Holdings PLC
14 September 2021
 

LEI: 2138001P49OLAEU33T68

 

Phoenix Group's Internal Model Harmonisation application is approved by the PRA

 

The Board of Phoenix Group Holdings plc ("the Group") is pleased to announce that the Prudential Regulation Authority ("PRA") has approved its application to harmonise its legacy Phoenix and Standard Life internal models.

 

This single, more sophisticated harmonised Internal Model will provide deeper insights into our risk profile which further strengthens the Group's risk management approach and decision making, as well as delivering significant capital synergies through diversification and improved risk modelling.

 

The harmonised Internal Model will go live effective 30 September 2021 and is currently estimated to increase the Group's Solvency II ("SII") Surplus by c.£0.4 billion. It is expected that c.£0.1 billion of the increased SII Surplus will then emerge as an acceleration of cash in 2022, after an appropriate period of operation.

 

The harmonised Internal Model also delivers a reduced capital strain for the Group's Bulk Purchase Annuity ("BPA") new business and unlocks a wider pipeline of future management actions including the execution of Part VIIs, the delivery of further enhancements to the Group's credit risk modelling capabilities and the foundation to bring ReAssure onto the new Internal Model in time. It will also support the Group in delivering future value accretive M&A.

 

-------------------------------------------------------------------------------------------------------------------------------------------------------

Enquiries

Investors/analysts:

Claire Hawkins, Director of Corporate Affairs, Phoenix Group

+44 (0)20 3735 0575

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0)20 3735 0160

Media:

Douglas Campbell, Teneo

+44 (0)775 313 6628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0)20 3735 0922

-------------------------------------------------------------------------------------------------------------------------------------------------------

Legal Disclaimers

This announcement in relation to Phoenix and its subsidiaries (the "Group") contains forward-looking statements about the Group's current plans, goals and expectations relating to future financial events, conditions, performance, results, strategy and/or objectives. Statements containing the words: 'believes', 'intends', 'will', 'expects', 'may', 'should', 'plans', 'aims', 'seeks', 'continues', 'targets' and 'anticipates' or other words of similar meaning are forward-looking. Such forward-looking statements involve risk and uncertainty because they relate to future events and circumstances that are beyond the Group's control. As a result, such future events and the Group's actual future financial condition, performance and results may differ materially from the plans, goals and expectations set out in the forward-looking statements in this announcement. The Group undertakes no obligation to update any of the forward-looking statements contained within this announcement. References in this announcement to Solvency II Surplus should be read in conjunction with the relevant footnotes set out in the 2021 Half Year Results Announcement of 11 August 2021.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAGZGMLFDDGMZM
Date   Source Headline
31st Jan 20222:00 pmRNSTotal Voting Rights
28th Jan 20227:09 amRNSStrategic Investor Update
18th Jan 20226:00 pmRNSHolding(s) in Company
18th Jan 20226:00 pmRNSHolding(s) in Company
17th Jan 20221:00 pmRNSDirector/PDMR Shareholding
14th Jan 20225:00 pmRNSHolding(s) in Company
12th Jan 20227:00 amRNSResult of Secondary Placing in Phoenix Group Hldgs
11th Jan 20225:09 pmRNSProposed Secondary Placing in Phoenix Group Hldgs
11th Jan 20227:00 amRNS2021 Bulk Purchase Annuity Transactions
7th Jan 20222:30 pmRNSDirector/PDMR Shareholding
31st Dec 202112:00 pmRNSTotal Voting Rights
30th Dec 20214:30 pmRNSDirector/PDMR Shareholding
22nd Dec 202112:00 pmRNSChange of Auditor
20th Dec 20211:00 pmRNSBlock listing Interim Review
10th Dec 20214:00 pmRNSDirector/PDMR Shareholding
30th Nov 20212:15 pmRNSTotal Voting Rights
9th Nov 202110:15 amRNSDirector/PDMR Shareholding
1st Nov 20214:52 pmRNSArk Life Assurance Sale Completion
29th Oct 20214:30 pmRNSTotal Voting Rights
8th Oct 20219:30 amRNSDirector/PDMR Shareholding
30th Sep 20215:00 pmRNSTotal Voting Rights
27th Sep 202111:00 amRNSDirector/PDMR Shareholding
14th Sep 20212:07 pmRNSInternal Model Harmonisation Approval
8th Sep 20214:15 pmRNSDirector/PDMR Shareholding
8th Sep 20214:15 pmRNSDirector/PDMR Shareholding
1st Sep 202110:00 amRNSTotal Voting Rights
25th Aug 202112:00 pmRNSDirector/PDMR Shareholding
20th Aug 202111:45 amRNSDirector/PDMR Shareholding
20th Aug 202111:45 amRNSDirector/PDMR Shareholding
16th Aug 202112:00 pmRNSDirector/PDMR Shareholding
12th Aug 20214:00 pmRNSDirector/PDMR Shareholding
11th Aug 20217:00 amRNS2021 Half Year Results
9th Aug 20214:30 pmRNSDirector/PDMR Shareholding
30th Jul 202111:45 amRNSTotal Voting Rights
13th Jul 20217:00 amRNSSale of Ark Life Assurance Company
8th Jul 20214:20 pmRNSDirector/PDMR Shareholding
1st Jul 20214:00 pmRNSTotal Voting Rights
29th Jun 20214:15 pmRNSHolding(s) in Company
25th Jun 20214:00 pmRNSDirector/PDMR Shareholding
24th Jun 20215:15 pmRNSBlock listing Interim Review
23rd Jun 20215:30 pmRNSPhoenix Group Holdings
23rd Jun 20217:00 amRNSResult of Secondary Placing in Phoenix Group Hldgs
23rd Jun 20217:00 amRNSStrategic Investor Update and Board Change
22nd Jun 20214:40 pmRNSProposed Secondary Placing in Phoenix Group Hldgs
16th Jun 20213:00 pmRNSBlock Listing Application
15th Jun 202112:00 pmRNSDiscussions in Respect of Sale Discontinued
9th Jun 20218:30 amRNSDirector/PDMR Shareholding
28th May 20212:00 pmRNSTotal Voting Rights
20th May 20214:00 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSStatement in Response to Press Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.